Bench under the tree in the Royal Botanic Gardens in London

The Opportunity of TEMPO and ACCESS for Digital Health Device Manufacturers

Start
The Food and Drug Administration (FDA) and Centers for Medicare & Medicaid Services (CMS) are offering digital health device manufacturers a combination of a new pathway to market and a payment system. Our FDA: Drug & Device Team explores how the combination offers an attractive opportunity for new use cases in a real-world setting….
By: Alston & Bird
Previous Story

FDIC extends comment period on proposed requirements for banks seeking to issue stablecoins under GENIUS Act

Next Story

Surveillance Pricing: A Burgeoning Privacy Issue